Literature DB >> 8209918

Smith-Lemli-Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: probable disruption of an SLOS gene.

M Wallace1, R T Zori, T Alley, E Whidden, B A Gray, C A Williams.   

Abstract

A 3-month-old infant girl had manifestations of the Smith-Lemli-Opitz syndrome (SLOS) including typical positional anomalies of the limbs, apparent Hirschsprung disease, cataracts, ptosis, anteverted nares, cleft of the posterior palate, small tongue, broad maxillary alveolar ridges, and abnormally low serum cholesterol levels. Chromosomal analysis showed a de novo balanced translocation interpreted as 46,XX,t(7;20)(q32.1;q13.2). We hypothesize that the translocation breakpoint in this case interrupts one SLOS allele and that the other allele at the same locus has a more subtle mutation that was inherited from the other parent. This case, as well as cytogenetic observations in other SLOS cases, suggests that SLOS could be due to autosomal recessive mutation at a gene in 7q32.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8209918     DOI: 10.1002/ajmg.1320500414

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

Review 1.  Radiographic features of the skeleton in disorders of post-squalene cholesterol biosynthesis.

Authors:  Massimiliano Rossi; Christine M Hall; Raymonde Bouvier; Sophie Collardeau-Frachon; Frédérique Le Breton; Martine Bucourt; Marie Pierre Cordier; Christine Vianey-Saban; Giancarlo Parenti; Generoso Andria; Martine Le Merrer; Patrick Edery; Amaka C Offiah
Journal:  Pediatr Radiol       Date:  2015-02-03

Review 2.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

3.  Molecular analysis of deletion (17)(p11.2p11.2) in a family segregating a 17p paracentric inversion: implications for carriers of paracentric inversions.

Authors:  S P Yang; S I Bidichandani; L E Figuera; R C Juyal; P J Saxon; A Baldini; P I Patel
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.

Authors:  H R Waterham; F A Wijburg; R C Hennekam; P Vreken; B T Poll-The; L Dorland; M Duran; P E Jira; J A Smeitink; R A Wevers; R J Wanders
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

5.  Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromes.

Authors:  V Cormier-Daire; C Wolf; A Munnich; M Le Merrer; A Nivelon; D Bonneau; H Journel; F Fellmann; F Chevy; C Roux
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

6.  Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patient.

Authors:  T L Alley; B A Gray; S H Lee; S W Scherer; L C Tsui; G S Tint; C A Williams; R Zori; M R Wallace
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

7.  Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.

Authors:  A K Ryan; K Bartlett; P Clayton; S Eaton; L Mills; D Donnai; R M Winter; J Burn
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.